Recro Pharma, Inc. To Purchase Drug Manufacturing Facility In Georgia

By

Recro Pharma, Inc., a specialty pharmaceutical firm with offices in Malvern and Ireland, is purchasing a Georgia manufacturing facility from Alkermes PLC and global rights to that company’s experimental pain treatment, the Wall Street Journal reports.

Recro Pharma is focused on developing non-opiod therapeutics to treat acute post operative pain.  The sale is set for the second quarter and is reportedly for $50 million up front and $120 million in milestone payments.

The deal also adds to Recro’s portfolio the rights to Alkermes’ pain treatment Meloxican IV/IM. Read the story here.

_______

Top Top photo credit: Greg McMullin via photopin cc

 

Tags: , , , ,

Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

Hidden
VT Yes
This field is for validation purposes and should be left unchanged.
Advertisement
Creative Capital logo

You Might Also Like

Rite AidPharma & Biotech

WSJ: Rite Aid Strikes Deal To Transfer Control Over To Creditors, Settle Opioid Claims

Katalin Karikó in her lab in 1989.Pharma & Biotech

Abington's Katalin Karikó's New Book Shares Her Journey from Rejection to COVID-19 Vaccine Hero

Endo headquarters.Pharma & Biotech

Endo International in Malvern to Pay $465M in Opioid Settlement

Researcher working with microplate panel for diseases diagnosis in the laboratory. Doctor working with microplatePharma & Biotech

Malvern-Based Venatorx Pharmaceuticals Expects Big News About Its Lead Antibiotic Candidate